Treatment of Status Epilepticus At and After T1 With Diazepam Nasal Spray: A Combined Cohort Analysis (P8-9.013)
To assess diazepam nasal spray (Valtoco®) to treat early status epilepticus (SE) episodes in patients with epilepsy.
Authors
- Tracy A. Glauser (ORCID: https://orcid.org/0000-0003-1520-2732)
- Evelyn Shih
- Randa Jarrar (ORCID: https://orcid.org/0000-0001-9373-0579)
- Danielle A. Becker (ORCID: https://orcid.org/0000-0002-4792-8055)
- Enrique J. Carrazana (ORCID: https://orcid.org/0000-0001-8788-0722)
- Eric Segal (ORCID: https://orcid.org/0000-0002-9986-6394)
- Jurriaan M. Peters (ORCID: https://orcid.org/0000-0002-6725-2814)
- John M. Stern (ORCID: https://orcid.org/0000-0002-3549-1642)
- Adrián L. Rabinowicz (ORCID: https://orcid.org/0000-0003-1299-0606)
Institutions
- University of Hawaiʻi at Mānoa (US)
- Cincinnati Children's Hospital Medical Center (US)
- Boston Children's Hospital (US)
- Hackensack University Medical Center (US)
- Harvard University (US)
- University of California, Los Angeles (US)
- The Ohio State University Wexner Medical Center (US)
- NorthEast Regional Epilepsy Group (US)
- Phoenix Children's Hospital (US)
- Neurelis (United States) (US)
- Florida Atlantic University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210501
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47